Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Improved high-efficiency human autologous Terg (Regulatory T cell) separation and amplification method

A blood cell separator and cell technology, which is applied in the field of separation and expansion of human autologous Treg cells, can solve the problems of small ratio, low separation efficiency, and low Treg cell separation rate, and achieve the effect of avoiding waste and slight impact

Inactive Publication Date: 2018-11-13
SHANDONG UNIV QILU HOSPITAL
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the proportion of autologous Treg cells in peripheral blood is small (this is more prominent in patients), the isolation efficiency is low, and the expansion is difficult, which ultimately leads to the low yield of cells and becomes the main bottleneck limiting Treg cell immunotherapy.
This protocol aims to solve the problem of low Treg cell isolation rate

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] The present invention provides a technical solution: an improved and efficient method for isolating and expanding human autologous Treg cells. The specific steps of the improved and highly efficient method for isolating and expanding human autologous Treg cells are as follows:

[0033] S1: 5000mL of peripheral blood can be processed by a blood cell separator (apheresis machine) with 1-2 cycles, and PBMCs of the order of 10^9-10^10 can be obtained. The separated PBMCs are removed from the suspended cells by passing them through a 30um nylon mesh centrifuge at 300g for 10 minutes, discard the dry supernatant to remove dead cells;

[0034] S2: Labeling non-CD4+ cells:

[0035] 1) After resuspending with 90ul MACS buffer (per 107 cells), add 10ul Biotin labeled Cocktail antibody, mix well, and incubate at 4°C for 10min,

[0036] 2) Add 20ul anti-Biotin microbeads, incubate at 4°C for 15min,

[0037] 3) Add 1mL MACS buffer, centrifuge at 300g at 4°C for 10min and suck off ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an improved high-efficiency human autologous (Regulatory T cell) separation and amplification method. The improved high-efficiency human autologous separation and amplificationmethod comprises the following steps: S1, treating 5000mL of PB (Peripheral Blood) through a blood cell separator (single sampling machine) in 1 to 2 cycles, obtaining PBMCs (Peripheral Blood Mononuclear Cells) in order magnitude of 10*9 to 10*10, sieving separated PBMCs through a nylon net of which the pore diameter is 30 mum, and removing a cell cluster in suspension cells; S2, labeling non-CD4+ cells; S3, removing the non-CD4+ cells through negative selection of an LD separation column; S4, labeling cd25+ cells on an antibody; S5, positively selecting the CD25+ cells through an MS column.According to the improved high-efficiency human autologous separation and amplification method disclosed by the invention, 5000mL of peripheral blood can be treated through the blood cell separator (single acquisition machine) in 1 to 2 cycles, the PBMCs (Peripheral Blood Mononuclear Cells) in order magnitude of 10*9 to 10*10 can be obtained, and mononuclear cells of which the number is 100 timesor above of the number of the mononuclear cells obtained through a traditional blood sampling method can be easily obtained; other blood components are in direct feedback, so that waste is avoided, and the influence on total blood component and blood cell count of a patient is more slight.

Description

technical field [0001] The invention relates to the technical field of Treg cell separation, in particular to an improved and efficient method for separating and expanding human autologous Treg cells. Background technique [0002] CD4+CD25+Foxp3+ regulatory T cell (Regulatory T cell, Treg) is a cell population with immune regulation function, which can inhibit the immune response of autoreactive T cells, inhibit the activation of traditional T cells and promote some inhibitory functions. The secretion of cytokines, etc., play an important role in maintaining the stability of the internal environment of the body and inducing the tolerance of the graft. It is an important way for the body to actively acquire and maintain self-tolerance. [0003] Treg can secrete IL-10, TGF-B, express Foxp3 and CTLA-4 molecules, etc., inhibit the immune response of self-reactive T cells, inhibit the activation of traditional T cells, and promote some inhibition through direct cell-to-cell conta...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N5/0783
CPCC12N5/0637C12N2509/00
Inventor 赵汝星
Owner SHANDONG UNIV QILU HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products